ASTERIXIS AS A SIDE-EFFECT OF CARBAMAZEPINE THERAPY

被引：8

作者：

RITTMANNSBERGER, H

LEBLHUBER, F

SOMMER, R

机构：

[1] WAGNER JAUREGG KRANKENHAUSE,NEUROPSYCHIAT GERONTOL ABT,A-4020 LINZ,AUSTRIA

[2] WAGNER JAUREGG KRANKENHAUSE,MED CHEM LAB DIAGNOST ABT,A-4020 LINZ,AUSTRIA

来源：

KLINISCHE WOCHENSCHRIFT | 1991年 / 69卷 / 06期

关键词：

ASTERIXIS; CARBAMAZEPINE; LITHIUM; CLOZAPINE;

D O I：

10.1007/BF01666855

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A patient developed asterixis 13 weeks after starting a therapy with carbamazepine. Serum concentration of carbamazepine was within the therapeutic levels. Further factors which might have provoked asterixis were an impairment of pulmonary function and the combination with a neuroleptic and lithium. Since the latter risk factors had already been present for a long time, it may be assumed that the addition of carbamzepine triggered the development of asterixis.

引用

页码：279 / 281

页数：3

共 11 条

[1]

ADAMS R. D., 1949, TRANS AMER NEUROL ASSOC, V74, P217

[2] HYPERAMMONEMIA IN ASTERIXIS INDUCED BY CARBAMAZEPINE - 2 CASE-REPORTS [J].